share_log

大成生化科技发布2023年度业绩 股东应占溢利42.25亿港元同比扭亏为盈

Dacheng Biochemical Technology Announces 2023 Annual Results: Profit attributable to shareholders of HK$4.225 billion turned a year-on-year loss into a profit

新浪港股 ·  Mar 28 22:52

Dacheng Biochemical Technology (00809) announced its annual results for the year ended December 31, 2023. The Group achieved revenue of HK$1,374 billion during the period, a significant increase over the previous year; profit attributable to company owners was HK$4.225 billion; loss attributable to company owners was HK$1,443 billion in the same period last year; basic profit per share was HK$47.4 cents.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment